Navigation Links
Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH
Date:12/1/2008

-- Conference Call Scheduled for Tuesday, December 9 at 11:00 am ET to Discuss Phase 2 Study Results in AML --

SOUTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics, today announced new data from its studies of voreloxin in acute myeloid leukemia (AML) will be presented during the 50th American Society of Hematology (ASH) Annual Meeting in San Francisco, California, December 5-9, 2008. Researchers will present updated interim data from the company's ongoing Phase 2 clinical trial of single-agent voreloxin (formerly SNS-595) for elderly patients with newly diagnosed AML and from its Phase 1b/2 study of voreloxin in combination with cytarabine for relapsed/refractory AML. In addition, results from the Phase 1 study of SNS-032, a selective inhibitor of cyclin dependent kinases 2, 7 and 9, in both chronic lymphocytic leukemia and multiple myeloma will be presented. Following are the details on each of these data presentations.

Sunday, December 7, 2008

Viewing: 9:00 a.m. to 8:00 p.m. PT

Presentation Time: 6:00 p.m. to 8:00 p.m. PT

Hall A, MosconeCenter

Abstract #1951

Title: "Phase 2 Study of Voreloxin (Formerly Known as SNS-595) as Single Agent Therapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia (AML): Preliminary Safety and Clinical Responses (The REVEAL-1 Study)"

Poster Board II-45

Abstract #1955

Title: "Voreloxin (formerly known as SNS-595) in Combination with Cytarabine Demonstrates Preliminary Clinical Responses in a Phase 1 Study in Relapsed/Refractory Acute Myeloid Leukemia"

Pos
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
2. SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases
3. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
4. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
5. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
6. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
7. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
8. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
9. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
10. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
11. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... /CNW/ -   The ... Canada tests confirmed it contains two undeclared amphetamine-like drug ... The distributor, Empire Health Distribution of Terrebonne, ... stores across Canada .  Jetfuel Superburn ... loss and increased energy. What consumers ...
(Date:12/24/2014)... 24, 2014  Novastem, a leader in regenerative ... in its study for ischemic stroke at Clinica ... ischemic strokes account for 87 percent of all ... in the study, entitled "Internal Research Protocol in ... Stem Cells and Intrathecal Administration of Neural Stem ...
(Date:12/24/2014)... 24, 2014  Actavis plc (NYSE: ... received a complete response letter from the U.S. ... Drug Application (NDA) for the fixed-dose combination (FDC) ... hypertension.   Photo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... the receipt of a complete response letter, Actavis ...
Breaking Medicine Technology:"Jetfuel Superburn" recalled after Health Canada tests find undeclared drug ingredients 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4
... 4, 2011 Cumberland Pharmaceuticals Inc. (Nasdaq: ... new senior credit agreement with Bank of America.  Pursuant to ... of credit to $10 million, which is expandable to $20 ... has been extended to December 2014. The new ...
... Mo., Aug. 4, 2011 Purdue Pharma, L.P., ... antiseptic to Children International , a U.S.-based ... world. To view the multimedia assets ... (Photo: http://photos.prnewswire.com/prnh/20110804/MM46982 ...
Cached Medicine Technology:Cumberland Pharmaceuticals Inks New Bank Financing Deal With Bank of America 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 3
(Date:12/25/2014)... 25, 2014 “ SmileStix ” was featured ... the latest and coolest mobile applications on the iOS, Android, ... host of NewsWatch, conducted the app review and shared with ... personal stickers. , The old saying goes, “A picture says ... words that can describe a single image, because each picture ...
(Date:12/25/2014)... 25, 2014 Plugin creators from Pixel ... A fully customizable business presentation tool made specifically for ... ProFire 5k business tool, users can now display their ... of Pixel Film Studios. “ProFire 5k gives users a ... add professionalism to a presentation” , Pixel Film Studios ...
(Date:12/25/2014)... Residents at Abernethy Laurels ... their generous spirit by providing holiday gifts to ... Network- Grandparents Raising Grandchildren program. , Following a ... largest Christmas tree on the campus of the ... of the Abernethy Village Association (AVA). Each holiday ...
(Date:12/25/2014)... Rosa, CA (PRWEB) December 25, 2014 ... department visits and 2 million hospital admissions across the ... and Prevention ). The CDC’s National Hospital Ambulatory ... departments through a survey conducted in 2010. They estimated ... department visits that resulted in a primary diagnosis of ...
(Date:12/25/2014)... Parker & Sons, Inc. an industry leader ... quality regarding heating, cooling and plumbing services in the ... the “Queen of Clean” for impressive contractor services in ... over the years for providing outstanding quality customer service ... services for both homeowners and businesses. Linda Cobb, known ...
Breaking Medicine News(10 mins):Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:Retirement Community Residents Make Impact During Holiday Season 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 3
... , RICHMOND, Calif., July 22 Transcept ... company focused on the development and commercialization of proprietary products ... announced today that Glenn A. Oclassen, President & Chief Executive ... Healthcare Conference in New York City on Wednesday, August 5, ...
... , , , ... Baxa Corporation announces the launch of updated, interactive functionality to the ... content features a unique interface that grants users a more in-depth view ... can zoom in to see high-resolution product photos and, on key products, ...
... , , , ... Nine hospital and health system clients of healthcare information technology ... ) have been named 2009 Most Wired award winners, according ... the July issue of Hospitals & Health Networks magazine. , ...
... , , WASHINGTON, July ... and public policy will look for ways to combat the ... a summit today co-convened by The AMERIGROUP Public Policy Institute ... Developing Families Center in Northeast, Washington, D.C., an integrated family ...
... , The National Comprehensive Cancer Network ... the Comparative Effectiveness of health care technologies in cancer care. This ... Effectiveness in Cancer Care to be held in December 2009 , ... The National Comprehensive Cancer Network (NCCN) ...
... , WALTHAM, Mass., July 22 ... on medical technology market intelligence, the recent Centers for ... hospital-acquired infections are resulting in adoption of antimicrobial-coated access ... MRG,s US Markets for Vascular Access Devices 2009 ...
Cached Medicine News:Health News:Transcept Pharmaceuticals to Present at BMO Capital Markets Healthcare Conference on August 5, 2009 2Health News:Transcept Pharmaceuticals to Present at BMO Capital Markets Healthcare Conference on August 5, 2009 3Health News:Transcept Pharmaceuticals to Present at BMO Capital Markets Healthcare Conference on August 5, 2009 4Health News:Baxa Launches Enhanced Online Product Content 2Health News:Nine CareTech Solutions Client-Hospitals Named 2009 Most Wired Winners 2Health News:Nine CareTech Solutions Client-Hospitals Named 2009 Most Wired Winners 3Health News:Nine CareTech Solutions Client-Hospitals Named 2009 Most Wired Winners 4Health News:AMERIGROUP Public Policy Institute, Black Leadership Forum, Inc. Convene Summit to Examine Preterm Birth Policy Solutions 2Health News:AMERIGROUP Public Policy Institute, Black Leadership Forum, Inc. Convene Summit to Examine Preterm Birth Policy Solutions 3Health News:NCCN Will Convene National Policy Summit on Comparative Effectiveness in Cancer Care 2Health News:NCCN Will Convene National Policy Summit on Comparative Effectiveness in Cancer Care 3Health News:Following CMS Cuts to Reimbursement for Medical Errors, New Devices Aimed at Reducing Nosocomial Infections Emerge 2Health News:Following CMS Cuts to Reimbursement for Medical Errors, New Devices Aimed at Reducing Nosocomial Infections Emerge 3
Adjust-A-Tip cautery....
Thru cut kerrison style punch 30 deg, 2.75 X 1.4 mm cut, 110 working length....
3 mm, 130 degree upwards cutting, detachable....
Sabre 180 is a powerful niche generator....
Medicine Products: